Skip to content
Screener

Xylem XYL Finance Lease ROU Asset Amortization

Finance Lease ROU Asset Amortization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.8M-76.7%
Xylem logo
XylemXYL
$9M+28.6%
RB Global logo
RB GlobalRBA
$5.5M+41.0%
Insmed logo
InsmedINSM
$678K0.0%
Kimberly-Clark logo
Kimberly-ClarkKMB
$3.75M+7.1%
Vulcan Materials Company logo
Vulcan Materials CompanyVMC
$1.7M-19.0%

Other financials

Income statement

See full
Revenue$2.3B+1.5%
Gross profit$963.0M+8.0%
Operating income$390.0M+27.9%
Net income$263.0M+16.4%
EPS (diluted)$1.11+19.4%

Balance sheet

See full
Cash & equivalents$1.3B+9.1%
Total debt$3.6B+63.6%
Total equity$10.4B-5.9%
Total assets$17.3B+0.9%

Cash flow

See full
Operating cash flow$290.0M-4.9%
CapEx$89.0M-9.2%
Free cash flow$201.0M-2.9%

Valuation

See full
Market cap$28.2B-19.3%
Enterprise value$30.51B-15.2%
P/E27.7×-9.6×
P/S3.1×-0.9×

Profitability

See full
Gross margin39.2%+1.4pp
Operating margin14.5%+2.1pp
Net margin11.2%+0.4pp
FCF margin10.5%+0.4pp

Returns & leverage

See full
Return on equity9.5%+0.7pp
Debt / equity0.3×+0.1×
Current ratio1.6×-0.3×